Shivalik Rasayan Share Price

Shivalik Rasayan Limited, with its corporate operations in New Delhi, functions as a manufacturer of agrochemicals and active pharmaceutical ingredients (APIs) in India. The company was incorporated in 1979 and is headquartered in the national capital. Shivalik Rasayan operates through two business segments: Agrochemicals and APIs, and also includes a pharma formulation segment. The company is a producer of Malathion Technical and Dimethoate Technical, which are organophosphorus-based insecticides. It also manufactures a diverse range of other insecticides, fungicides, and custom chemicals. In its pharmaceutical division, the company develops and manufactures APIs for oncology, ARVs, cardiovascular, metabolic disorders, and immunology. Shivalik Rasayan offers comprehensive solutions from product selection to commercialization for a range of oncology and non-oncology products. The company is based in New Delhi, India.

Shivalik Rasayan share price on NSE and BSE signifies how market participants react to the company’s operational performance and the overall developments in the agrochemical and pharmaceutical sectors. The company’s financial health depends on production volumes of key technical-grade pesticides, raw material costs, demand from the agricultural sector, and the progress of its API development pipeline. Shivalik Rasayan stock price is influenced by various factors such as earnings, regulatory approvals for its pharma products, global agrochemical demand trends, and the success of its expansion into high-value oncology APIs. In the longer run, strategies such as capacity expansion, new product registrations, and deepening its presence in the pharma segment affect the stock market sentiments. All these factors need to be monitored closely to have an idea about the company’s stock price movements.

Shivalik Rasayan live share price provides real-time information about the last price traded, bid and ask prices, and volume traded. These indicators represent market activity and liquidity, reflecting investor response to corporate announcements, economic conditions, and sector news. Constant monitoring of the Shivalik Rasayan live price helps in observing short term price volatility and shows how a stock moves relative to the broader chemical index. Furthermore, monitoring Shivalik Rasayan stock price movements helps investors understand real-time market sentiment, price fluctuations, and trading behaviour. It allows them to evaluate short-term performance, and respond to news, quarterly results, or sector trends that may influence the company’s valuation and overall investment outlook.

Shivalik Rasayan Limited Company Fundamentals

a. Company Background

Shivalik Rasayan Limited was incorporated in 1979 and is engaged in the manufacturing of agrochemicals and active pharma ingredients (APIs). The company operates primarily in the chemical segment, supplying products such as technical-grade pesticides, insecticides, and custom chemicals. It also develops and manufactures APIs for oncology and other therapeutic areas. Its manufacturing operations are based in India, with corporate functions managed from its administrative offices in New Delhi. Over time, the company has expanded its product portfolio and entered the pharmaceutical segment to diversify its revenue streams. Financial performance is assessed through standard metrics such as revenue growth, operating margins, and capacity utilisation. Market valuation indicators such as the P/E ratio are used by analysts for comparative assessment within the chemical manufacturing sector. Overall fundamentals are influenced by raw material availability, demand cycles in agriculture and pharmaceuticals, and input cost fluctuations.

b. Company Product Lines

• Agrochemical products: Dimethoate technical used in the preparation of formulations for the control of various insects and mites

• Malathion technical: an organophosphorus-based contact insecticide used in agricultural production of various food and feed crops

• Other insecticides: Chlorantraniliprole, Chlorfenapyr, Pymetrozine, Novaluron, and Bifenthrin

• Fungicides: Azoxystrobin, Trifloxystrobin, and Kresoxim-methyl products

• Custom manufacturing of chemicals for third parties

• Active Pharmaceutical Ingredients (APIs) in oncology, ARVs, cardiovascular, metabolic disorders, and immunology

• Oncology products include Azacitidine, Busulfan, Bortezomib, and various others

• The company also develops and manufactures non-oncology products

c. Company Revenue Model

• Domestic sales of agrochemical products to distributors, agricultural input companies, and industrial buyers across India

• Export sales of agrochemicals to international agricultural markets

• Revenue from custom manufacturing of chemicals for third-party clients

• Income from the development and sale of APIs to pharmaceutical companies

• Revenue performance is primarily influenced by demand for agrochemical products, raw material costs, and selling price realizations in domestic and export markets, as well as the success of its API development and commercialization efforts

d. Geographic Presence

• Corporate headquarters located in New Delhi, India

• Manufacturing facilities located in India

• Domestic distribution network across India serving agricultural and pharmaceutical customers

• Export markets served through international distribution channels and direct customer relationships

• The company supplies its products to customers in both domestic and international markets

e. Key Milestones

• 1979: Incorporation of Shivalik Rasayan Limited

• 2016: Initial Public Offering (IPO) listing on stock exchanges

• Development of oncology API portfolio including Azacitidine, Busulfan, and Bortezomib

• Recent years: Continued focus on product mix optimisation, expansion of API pipeline, and operational efficiency improvements

f. Industry Perspective

The agrochemical manufacturing industry is capital-intensive and closely linked to demand from the agricultural sector. Demand trends are influenced by economic activity, monsoon patterns, crop prices, and pest infestation cycles. The pharmaceutical API industry is similarly influenced by global demand for generic drugs, regulatory approvals, and patent expiries. Both industries are affected by fluctuations in raw material prices such as chemical precursors, along with energy and logistics costs. Environmental regulations and sustainability requirements are increasingly shaping production practices and capital investment decisions. Companies in the sector must manage cyclical demand patterns and cost volatility while maintaining operational efficiency. These factors collectively influence financial performance and investor perception of firms like Shivalik Rasayan.

Shivalik Rasayan Limited Stock Market Presence: Listings & Index Representation

Shivalik Rasayan Limited is listed on the National Stock Exchange (NSE) under the symbol SHIVALIK and on the Bombay Stock Exchange (BSE) with the scrip code 539148. Shivalik Rasayan share price is actively traded on both exchanges. The company’s market presence is within the small-cap segment of the market. Due to its size and sector focus, Shivalik Rasayan stock price is generally tracked by investors interested in the agrochemical and pharmaceutical API industry.

Shivalik Rasayan Limited is part of several broad-based and sector-specific stock market indices, reflecting its position as a small-cap chemical company in India. While it is not included in benchmark indices like the Sensex or Nifty 50, it is a constituent of wider market indices such as the BSE SmallCap and BSE Commodities indices. Shivalik Rasayan share price finds representation in these indices based on its market standing. This presence helps investors track the stock relative to other agrochemical and pharmaceutical companies.

Shivalik Rasayan Limited Stock Performance and Share Price History

Shivalik Rasayan share price on NSE reflects its status as an agrochemical and API manufacturer in India. Performance is driven by production capacity utilization, raw material cost management, domestic distribution reach, and the company’s ability to manage operational expenses. Investors compare Shivalik Rasayan share price today with other chemical manufacturers and pharmaceutical API producers to gauge relative performance.

These underlying factors are often visible through real market movements across different periods. Similar trends are observed during earnings-driven movements. Broader sector strength has also played a role in supporting Shivalik Rasayan share price. In addition to operational and sector-led factors, corporate actions such as the company’s focus on developing a strong oncology API pipeline can also have a significant impact on Shivalik Rasayan share price movements as these initiatives drive future growth expectations. This shows how strategic product development can trigger investor interest, even within a regulated chemical framework influenced by raw material price cycles and global demand trends.

While short-term movements reflect events and announcements, longer-term valuation trends are visible through Shivalik Rasayan share price 52-week high and low, providing context beyond daily or weekly changes. Based on available data, the stock’s 52-week high stood at approximately 1,010.00, while the 52-week low stood at approximately 206.75 to 265.65 depending on the reporting period. Highs suggest stronger agrochemical demand and positive sentiment around its pharma foray, while lows align with market corrections or sector volatility. These levels capture impacts of trade policies, global chemical trends, and earnings visibility, providing context for the stock’s historical performance.

Shivalik Rasayan’s stock performance reflects the trading behaviour of a small-cap agrochemical company operating within India’s manufacturing ecosystem. The company’s diversified portfolio across agrochemicals and pharma APIs has shaped its Shivalik Rasayan share price history. Over the past five years, the stock has shown periods of sharp gains and phases of consolidation. The stock delivered a positive annual return of approximately 44.4 percent in 2020, while recording negative returns in other years, underperforming the broader BSE Small Cap index over the one-year, three-year, and five-year periods. The stock underperformed the BSE Small Cap index which delivered positive returns over the same periods. More recently, the stock has shown a year-to-date negative return of approximately 21.6 percent and a one-month return of negative 15.7 percent. The beta of the stock stands at approximately 0.013 to 1.36 depending on the reporting period, indicating varying volatility compared to the broader market.

Shivalik Rasayan’s stock performance over time has closely followed India’s agrochemical demand and global API market trends. The share price showed positive momentum in 2020 when it was included in BSE Small Cap and other indices, reflecting the post-pandemic recovery in the chemical sector. However, periods of high raw material costs and competitive pressures have contributed to consolidation in the stock price. The company’s profit after tax declined in the latest quarter compared to the corresponding period of the previous year, primarily due to lower sales. The company’s net profit for the quarter ended December 2025 was significantly lower than the year-ago quarter, highlighting the volatility and cyclical nature of the chemical industry.

Despite COVID-19 disruptions, Shivalik Rasayan shares showed resilience during the pandemic recovery phase. While the broader chemical sector faced supply chain challenges, the company’s diversified product mix across agrochemicals and pharmaceutical APIs helped the stock recover from pandemic lows. The company has a workforce of 275 employees and continues to focus on its API development pipeline.

Shivalik Rasayan stock price has seen decreases due to several recurring reasons. A decline in agricultural demand or a drop in pesticide realizations directly impacts profitability and leads to selling pressure. Changes in government policy, such as stricter environmental regulations for chemical manufacturing or changes in import duties on raw materials, can also cause the stock to fall. Furthermore, any increase in operational costs like raw material procurement or energy expenses without a matching rise in product prices squeezes the company’s margins, making the stock less attractive. Periods of global economic slowdown that affect agricultural spending raise concerns about export volumes, leading to a drop in Shivalik Rasayan share price. The stock is also sensitive to raw material price movements; if chemical precursors prices rise significantly affecting input costs, it can lead to a decrease in Shivalik Rasayan stock price as investors adjust expectations for future margin growth. Broader market sell-offs in small-cap stocks also pull the price down, regardless of the company’s individual performance. A decrease in capacity utilization or lower sales in any product category directly hurts the company’s revenue, resulting in a lower valuation for Shivalik Rasayan share price.

Shivalik Rasayan Limited Investor Relevance and Role in Portfolio

Shivalik Rasayan Limited is a holding in small-cap and chemical sector portfolios, offering exposure to agrochemical manufacturing and pharmaceutical API development. Inclusion in chemical indices underscores its importance in India’s agrochemical manufacturing space. The company’s dual focus on agrochemicals and APIs, its position as a producer of key technical grade pesticides, and its developing oncology API portfolio make it a consideration for long-term allocations.

Shivalik Rasayan share price is influenced by the company’s ownership structure. Shivalik Rasayan equity is held by a broad mix of promoters, institutional investors, and retail investors, reflecting its standing in India’s chemical sector. Promoters hold a stable majority stake of approximately 41 to 47 percent in the company, reflecting strong internal control. Foreign institutional investors hold approximately 4.34 to 3.89 percent of the company’s shares, showing varied interest over time. Domestic institutional investors hold a negligible stake of approximately 0.12 to 0.88 percent in the company. The public and retail investors hold the remaining stake of approximately 28.5 to 31.95 percent in the company, showing an increasing trend of retail participation. The company’s management includes Executive Chairman Rahul Bishnoi, Managing Director Vimal Kumar Shrawat, and Executive Vice Chairman Suresh Kumar Singh. This investor base with stable promoter participation underscores the company’s role as a holding in both domestic and focused portfolios concentrating on agrochemical and pharmaceutical manufacturing.

Beyond fundamentals and ownership, Shivalik Rasayan stock is actively monitored in cash market segments, where trading volumes and delivery patterns reflect expectations on production levels, export orders, and regulatory policy actions affecting the chemical and pharmaceutical sectors. The stock is available for trading on both the NSE and BSE, allowing investors to take positions based on their outlook for the chemical sector. Market participants watch these trading indicators to gauge sentiment around quarterly results and policy announcements.

Technical indicators provide additional insight into short-term momentum shifts in the company’s stock price. While these indicators are primarily used for near-term trading decisions, they also help investors and portfolio managers understand broader market sentiment and anticipate potential volatility, especially around key events or announcements. In the short-term and weekly timeframe, the stock has exhibited price movements that are sensitive to broader chemical sector trends. Based on available data, the stock’s beta of approximately 0.013 to 1.36 indicates that the stock can range from lower to higher volatility compared to the broader market, depending on the measurement period. The company’s debt-to-equity ratio is minimal, reflecting a low-leverage balance sheet. The return on equity stands at moderate levels, while return on capital employed stands at modest levels, reflecting the capital-intensive nature of the chemical business. The company’s book value per share stands at a significant level, indicating that the stock is trading at a discount to its book value.

Overall, Shivalik Rasayan demonstrates a mixed volatility profile, with beta values varying across different measurement periods, making it sensitive to broader market movements and sector-specific factors such as raw material price fluctuations, agricultural demand, and API development progress.

Shivalik Rasayan Limited Sectoral Relevance and Peer Positioning

Shivalik Rasayan Limited sector relevance stems from its presence in the agrochemical industry, its position as a manufacturer of technical grade pesticides like Dimethoate and Malathion, its diversified portfolio of insecticides and fungicides, and its foray into pharmaceutical API manufacturing, establishing it as a focused small-cap specialty chemical provider supporting India’s agricultural and pharmaceutical sectors. Peer comparisons with companies in the agrochemical and API sector such as UPL, PI Industries, Sumitomo Chemical, Bayer Crop Science, Sharda Cropchem, Rallis India, Dhanuka Agritech, and India Pesticides focus on production capacity, product mix, export presence, and value-added product diversification rather than short-term stock moves. These benchmarks help investors assess operational scale, efficiency, and regulatory adherence. Institutional tracking of raw material prices (chemical precursors), agricultural demand trends, and pharmaceutical regulatory approvals further highlights Shivalik Rasayan positioning within India’s broader chemical manufacturing market.

Shivalik Rasayan P/E ratio reflects how investors perceive the company’s earnings relative to its revenue streams from agrochemical and API sales. Based on available data, the current P/E ratio varies across different sources, with some reporting a ratio of approximately 27 to 49 times, which is at a premium to the industry average. The company’s profit after tax has shown volatility in recent quarters, with the latest quarter net profit significantly lower than the same quarter of the previous year, reflecting the cyclical nature of the agrochemical business and challenges in the API segment. However, the company showed strong annual performance with profit after tax increasing in the full fiscal year. Overall, these changes highlight how market sentiment evolved alongside the company’s operational performance in a cyclical and transitional industry.

Alongside valuation, Shivalik Rasayan EPS provides insight into its operational performance and income generation from agrochemicals and API products. Based on available data, the company reported a TTM EPS that has varied across reporting periods. The company’s EPS for the latest quarter was lower compared to the same quarter of the previous year, reflecting the volatile nature of the chemical business. The company has a face value of 5 rupees per share and has declared dividends with a modest dividend yield.

Shivalik Rasayan market cap highlights its position as a small-cap player within India’s agrochemical sector. Based on recent data, the company’s market capitalization has fluctuated, standing at approximately 426 to 433 crore rupees depending on the reporting period. The company’s market cap has moved in line with investor perceptions of the company’s growth potential following the peak in its share price. From earlier years through more recent periods, the market cap showed an increasing trend as the company expanded its operations and entered the API segment, followed by a significant correction. This pattern reflects strong investor confidence during favourable agrochemical cycles and API development progress, followed by contraction during challenging periods impacted by rising raw material costs and global economic uncertainty. This decrease mirrors the correction in the Shivalik Rasayan share price from its 52-week high to recent levels.

Finally, Shivalik Rasayan earnings trajectory demonstrates the impact of its operational execution in a competitive and cyclical industry. In recent fiscal years, total income showed growth supported by the core agrochemical business. Based on available data, the company’s revenue from operations increased in the most recent fiscal year compared to the previous year, a strong percentage growth. Profit after tax also increased over the same period. However, quarterly performance has shown pressure on profits in certain quarters. The company has faced headwinds from fluctuating raw material prices, increased competitive pressures, and challenges in its API business segment. However, the company continues to maintain its market share in key technical pesticide products and develop its oncology API pipeline. These developments illustrate the cyclical nature of the agrochemical industry and the transitional nature of the API business, and the company’s position within this evolving sector.

Summary

Shivalik Rasayan Limited operates as an agrochemical and pharmaceutical API manufacturer serving domestic and international agricultural and pharmaceutical markets. Shivalik Rasayan share price moves largely with agricultural demand cycles, raw material cost fluctuations, and broader chemical sector conditions, while also being influenced by developments in its API pipeline. Shivalik Rasayan stock price reflects its specific position within the small-cap chemical manufacturing space. The company’s performance aligns with the operational results of its focused agrochemical portfolio and its developing API business, supported by a stable promoter base and a diversified product mix spanning both traditional agrochemicals and emerging pharmaceutical ingredients.